BeOne Medicines (ONC) Change in Inventory (2017 - 2026)

BeOne Medicines (ONC) has reported Change in Inventory for 10 consecutive years, with $71.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory rose 1901.81% year-over-year to $71.8 million; the TTM figure through Mar 2026 stood at $169.0 million (up 236.34% YoY), while the FY2025 annual figure was $93.2 million, up 1.83% from the prior year.
• Change in Inventory improved to $71.8 million in Q1 2026 per ONC's latest filing, from $70.5 million in the prior quarter.
• Across five years, Change in Inventory topped out at $88.6 million in Q4 2023 and bottomed at -$23.8 million in Q3 2024.
• Historically, Change in Inventory has averaged $26.7 million across 5 years, with a median of $28.6 million in 2022.
• Annual changes were most pronounced in 2024 — Change in Inventory sank 1842.71% — and 2026, when it surged 1901.81%.
• BeOne Medicines' Change in Inventory stood at -$18.9 million in 2022, then soared by 567.6% to $88.6 million in 2023, then declined by 10.38% to $79.4 million in 2024, then dropped by 11.18% to $70.5 million in 2025, then increased by 1.89% to $71.8 million in 2026.
• Business Quant data shows ONC's Change in Inventory at $71.8 million in Q1 2026, $70.5 million in Q4 2025, and $28.8 million in Q3 2025.